The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Perfusion Culture System-Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Perfusion Culture System-Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Publishing Date : Nov, 2025

License Type :
 

Report Code : 2011787

No of Pages : 91

Synopsis

The global market for Perfusion Culture System was estimated to be worth US$ 102 million in 2024 and is forecast to a readjusted size of US$ 180 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

In cell culture, perfusion is a process that uses a method to keep cells in a bioreactor while continuously exchanging culture medium.

The perfusion culture system is a cell culture technology in which fresh culture medium continuously enters the reactor after cells are inoculated into the culture system, while the culture medium continuously flows out. The perfusion culture system mimics the natural flow of fluid in vivo conditions, allowing for the growth of adherent cultures at scale with minimal space and variability.

The perfusion culture system is widely used in the fields of cell biology, cell engineering, bioengineering, etc., especially in the production of unstable proteins, cell therapy drugs, vaccines and other biological products. In addition, the system is also suitable for cell types that require high cell density culture, such as anchorage-dependent cells.

The core principle of the perfusion culture system lies in its unique liquid flow design. After the cells are inoculated in the system, fresh culture medium continuously enters the reactor through the pumping system, while the old culture medium is continuously discharged. In this process, the cells are retained in the reactor, and the culture medium is continuously updated to maintain the optimal growth conditions of the cells.

In recent years, with the rapid development of biotechnology and cell therapy, perfusion culture systems have become an important tool for life science research and biopharmaceutical production. Europe and North America started early in the field of perfusion culture systems, and their theoretical systems and research methods are relatively complete. European and North American scholars have made important breakthroughs in cell growth dynamics, metabolic regulation, and system optimization. In addition, well-known European and North American manufacturers such as Cytiva, Merck, and Sartorius continue to launch innovative products and technologies, which have promoted the widespread application of perfusion culture systems and biopharmaceutical production.

In the future, the application prospects of perfusion culture systems in the medical field are broad. With the rise of new treatment methods such as cell therapy and gene therapy, the demand for high-quality cell products will continue to increase. The perfusion culture system, with its high efficiency, stability, and controllability, will become one of the key technologies to meet this demand. In addition, with the continuous advancement of technology and the reduction of costs, the perfusion culture system is expected to be applied and promoted in more fields.

This report aims to provide a comprehensive presentation of the global market for Perfusion Culture System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Perfusion Culture System by region & country, by Type, and by Application.

The Perfusion Culture System market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Perfusion Culture System.

Market Segmentation

By Company

  • Cytiva
  • Merck
  • Sartorius
  • Getinge
  • Corning
  • Terumo BCT
  • Takasago
  • CELLEC Biotek AG
  • ALIT Biotech

Segment by Type

  • Long-Lasting Parts System
  • Single-Use Parts System

Segment by Application

  • Biopharmaceutical
  • 3D Cell Culture
  • Scientific Research
  • Others

Segment by Region

  • North America: United States, Canada, and Mexico
  • Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
  • Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
  • Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.

Index

Available Upon Request

Published By : QY Research

Why ‘The Market Reports’